.

Pharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

MOEXIPRIL HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Moexipril Hydrochloride, and what substitute generic drugs are available?

Moexipril Hydrochloride is a drug marketed by Teva, Glenmark Generics, Paddock Llc, Apotex Inc, Glenmark Pharms, and Heritage Pharms Inc. and is included in eight NDAs.

The generic ingredient in MOEXIPRIL HYDROCHLORIDE is hydrochlorothiazide; moexipril hydrochloride. There are thirty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; moexipril hydrochloride profile page.

Summary for Tradename: MOEXIPRIL HYDROCHLORIDE

Patents:0
Applicants:6
NDAs:8
Suppliers / Packagers: see list6
Bulk Api Vendors: see list24
Clinical Trials: see list988
Patent Applications: see list806
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MOEXIPRIL HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: MOEXIPRIL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
MOEXIPRIL HYDROCHLORIDE
moexipril hydrochloride
TABLET;ORAL076204-001May 8, 2003RXNoNo► Subscribe► Subscribe
Paddock Llc
MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL090096-001Sep 25, 2008DISCNNoNo► Subscribe► Subscribe
Apotex Inc
MOEXIPRIL HYDROCHLORIDE
moexipril hydrochloride
TABLET;ORAL078454-001Jun 2, 2008RXNoNo► Subscribe► Subscribe
Glenmark Generics
MOEXIPRIL HYDROCHLORIDE
moexipril hydrochloride
TABLET;ORAL090416-002Mar 30, 2010RXNoNo► Subscribe► Subscribe
Heritage Pharms Inc
MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; moexipril hydrochloride
TABLET;ORAL202150-001Mar 7, 2014RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc